Elevance Health Inc. (ANTM) has a consensus analyst rating of Buy, based on 37 analysts covering the stock. Of those, 27 recommend buying, 10 recommend holding, and 0 recommend selling.
The analyst consensus price target for ANTM is $529.05, representing a +9.6% upside from the current price of $482.58. Price targets range from a low of $335.00 to a high of $625.00.
